Amiodarone vs Lidocaine for ICU Nurses 2026 — Antiarrhythmic Choice in VT/VF Compared

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

When a patient is in ventricular tachycardia or fibrillation, two drugs dominate the antiarrhythmic conversation: amiodarone and lidocaine. Both live on the code cart and both live in the ACLS algorithm, but they behave very differently in the days that follow a rescue. Knowing their split personalities — amiodarone the broad, long-acting, organ-toxic one; lidocaine the narrow, fast, neuro-toxic one — makes you a sharper nurse in both the arrest and the aftermath.

The short version: In shock-refractory VF/pulseless VT, amiodarone is the ACLS first-line (300 mg IV push, then 150 mg), with lidocaine as the accepted alternative (1–1.5 mg/kg). Amiodarone is broad and long-acting but drops blood pressure acutely and carries serious long-term organ toxicity (thyroid, lung, liver, eyes, skin). Lidocaine is ventricular-only and clears fast, but toxic levels cause CNS effects — perioral numbness, confusion, seizures. Amiodarone needs an in-line filter and, for continuous infusion, ideally a central line.

In the arrest: what ACLS actually says

For a shockable rhythm (VF or pulseless VT) that persists after defibrillation and epinephrine, amiodarone is the preferred antiarrhythmic: 300 mg IV/IO push, with a second dose of 150 mg if needed. Lidocaine is a reasonable substitute when amiodarone isn't available or the team prefers it, dosed at 1–1.5 mg/kg with repeat boluses. Both are followed by a maintenance infusion if the patient achieves return of circulation and the arrhythmia was drug-responsive. In a stable (not arrested) wide-complex tachycardia, the same two agents appear, given more slowly — and here amiodarone's blood-pressure effect gets more attention because there's a live circulation to drop.

The acute side effect that changes your setup

Amiodarone drops the pressure — and it's partly the rate you give it. IV amiodarone causes hypotension, driven in part by the diluent and the infusion speed. In a code you push it fast because the alternative is death; in a stable patient you give it more slowly and watch the arterial line. It also prolongs the QT, so it isn't the drug for a torsades-type polymorphic VT driven by a long QT.

Lidocaine toxicity is neurologic first. Because lidocaine is metabolized by the liver and accumulates in low-output states and hepatic dysfunction, watch a patient on a lidocaine drip for the classic escalation: perioral or tongue numbness, metallic taste, tinnitus, dizziness, confusion, slurred speech → muscle twitching → seizures, and at the extreme, cardiovascular collapse. New CNS symptoms on a lidocaine infusion are toxicity until proven otherwise — slow or stop the drip and tell the provider.

The long tail: amiodarone's organ toxicity

Lidocaine's problems end when the drip ends. Amiodarone's don't. Amiodarone has an enormous half-life (weeks) and, especially with chronic use, a long list of end-organ toxicities: thyroid dysfunction (both hypo- and hyper-, because it's iodine-rich), potentially fatal pulmonary fibrosis/pneumonitis, hepatotoxicity, corneal deposits and optic issues, a blue-gray skin discoloration, and photosensitivity. A patient started on amiodarone in the ICU inherits a monitoring plan — thyroid, liver, and pulmonary function follow-up — that outlives their admission. Part of your discharge teaching is that this is not a casual medication.

The practical bedside details

Amiodarone requires an in-line filter and is incompatible with many drugs; the continuous infusion is ideally run through a central line because peripheral amiodarone can cause phlebitis and, with extravasation, tissue injury. Protect it from excessive light per your pharmacy's guidance. Lidocaine is comparatively simple to run but demands attention to the patient's liver and cardiac output, and to the running rate, because toxicity is dose- and level-driven. Never confuse cardiac lidocaine with lidocaine-with-epinephrine or topical formulations.

How the team chooses

	Amiodarone	Lidocaine
ACLS role (VF/pVT)	First-line (300 then 150 mg)	Alternative (1–1.5 mg/kg)
Spectrum	Broad (atrial & ventricular)	Ventricular only
Onset / duration	Slower onset, very long-acting	Fast on, fast off
Acute risk	Hypotension, QT prolongation	CNS toxicity (seizures)
Chronic risk	Thyroid, lung, liver, eye, skin	Minimal after drip stops
Line / setup	In-line filter, central line preferred	Peripheral OK; watch liver/output

Amiodarone's breadth and durability make it the default for most VF/VT and for patients who also have atrial arrhythmias or need lasting rhythm control — you accept the hypotension and the long-term monitoring in exchange. Lidocaine shines when you want a fast, reversible, ventricular-specific agent, when amiodarone is contraindicated or unavailable, or in some ischemia-driven VT. Neither is the answer for torsades from a long QT — that's magnesium and fixing the cause.

Bedside monitoring, in short: On amiodarone — watch blood pressure during infusion, use the in-line filter and ideally a central line, monitor QT, and set up the thyroid/liver/lung follow-up. On lidocaine — watch the neuro exam obsessively, know the patient's liver function and cardiac output, and treat any new confusion, twitching, or perioral numbness as toxicity. In both cases, keep defibrillation immediately available, because an antiarrhythmic is a bridge, not a guarantee.

Educational content for licensed clinicians. Always follow your facility's pharmacy dosing protocol and current ACLS guidelines. Not medical advice.

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.

Amiodarone vs Lidocaine — The Two Ventricular Antiarrhythmics You'll Push

In the arrest: what ACLS actually says

The acute side effect that changes your setup

The long tail: amiodarone's organ toxicity

The practical bedside details

How the team chooses

Related Articles